Is PKBO or RYLD a better dividend investment in 2026?

PKBO currently yields 8888.89% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: PKBO offers higher current income.

What is the dividend yield difference between PKBO and RYLD?

PKBO has a forward dividend yield of 8888.89% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 8876.75 percentage points.

Home › Compare › PKBO vs RYLD

PKBO vs RYLD: Dividend Comparison 2026

PKBO yields 8888.89% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PKBO wins by $17290949737713800.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PKBO

● Live price

8888.89%

Share price

$0.02

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$17290949737713800.00M

Annual income

$16,916,578,202,775,594,000,000.00

Full PKBO calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — PKBO vs RYLD

📍 PKBO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PKBO	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PKBO + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PKBO pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKBO

Annual income on $10K today (after 15% tax)

$755,555.56/yr

After 10yr DRIP, annual income (after tax)

$14,379,091,472,359,256,000,000.00/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, PKBO beats the other by $14,379,091,472,359,256,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKBO + RYLD for your $10,000?

PKBO: 50%RYLD: 50%

100% RYLD50/50100% PKBO

Portfolio after 10yr

$8645474868856900.00M

Annual income

$8,458,289,101,387,797,000,000.00/yr

Blended yield

97.83%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKBO buys

RYLD buys

No recent congressional trades found for PKBO or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPKBORYLD

Forward yield	8888.89% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$17290949737713800.00M ✓	$44.5K
Annual income after 10y	$16,916,578,202,775,594,000,000.00 ✓	$2,587.35
Total dividends collected	$17265985963886318.00M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: PKBO vs RYLD ($10,000, DRIP)

Year	PKBO Portfolio	PKBO Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$899,589	$888,888.89	$11,914	$1,213.65	+$887.7K → PKBO
2	$75,694,763	$74,732,202.61	$14,099	$1,351.30	+$75.68M → PKBO
3	$5,957,858,933	$5,876,865,536.53	$16,580	$1,494.55	+$5957.84M → PKBO
4	$438,676,028,838	$432,301,119,780.33	$19,384	$1,642.61	+$438676.01M → PKBO
5	$30,217,280,421,144	$29,747,897,070,286.80	$22,535	$1,794.70	+$30217280.40M → PKBO
6	$1,947,399,451,993,550	$1,915,066,961,942,926.00	$26,063	$1,950.00	+$1947399451.97M → PKBO
7	$117,429,004,658,116,600	$115,345,287,244,483,520.00	$29,995	$2,107.69	+$117429004658.09M → PKBO
8	$6,625,994,131,926,989,000	$6,500,345,096,942,805,000.00	$34,361	$2,266.99	+$6625994131926.95M → PKBO
9	$349,879,939,194,586,330,000	$342,790,125,473,424,500,000.00	$39,194	$2,427.12	+$349879939194586.25M → PKBO
10	$17,290,949,737,713,800,000,000	$16,916,578,202,775,594,000,000.00	$44,525	$2,587.35	+$17290949737713800.00M → PKBO

PKBO vs RYLD: Complete Analysis 2026

PKBO — Stock

Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company's proprietary toxin, PH-1 or Thailanstatin, a spliceosome modulator is being used to generate its first pipeline of novel ADC product candidates to address unmet needs in cancer patients. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency (AATD). The company is based in Palo Alto, California.

Full PKBO Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this PKBO vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKBO vs SCHD PKBO vs JEPI PKBO vs O PKBO vs KO PKBO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.